Pinnacle Associates’s CollPlant Biotechnologies CLGN Stock Holding History

Pinnacle Associates’s Portfolio CLGN Stock Details CLGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$255K	Buy	73,166 +18,143	+33%	+$69.9K	﹤0.01%	858
2026 Q1	$295K	Sell	55,023 -696	-1%	-$7.02K	﹤0.01%	807
2025 Q4	$780K	Buy	55,719 +5,000	+10%	+$102K	0.01%	566
2025 Q3	$1.36M	Hold	50,719	–	–	0.02%	458
2025 Q2	$690K	Buy	50,719 +1,800	+4%	+$37.3K	0.01%	570
2025 Q1	$1.26M	Sell	48,919 -50	-0.1%	-$1.76K	0.02%	453
2024 Q4	$1.76M	Buy	48,969 +2,158	+5%	+$87.7K	0.02%	390
2024 Q3	$2.99M	Sell	46,811 -9,625	-17%	-$471K	0.05%	297
2024 Q2	$2.8M	Buy	56,436 +3,390	+6%	+$188K	0.04%	314
2024 Q1	$2.84M	Buy	53,046 +6,235	+13%	+$337K	0.04%	321
2023 Q4	$2.99M	Sell	46,811 -1,020	-2%	-$55.8K	0.05%	300
2023 Q3	$2.66M	Sell	47,831 -634	-1%	-$41.9K	0.05%	311
2023 Q2	$3.95M	Buy	+48,465	New	+$3.53M	0.07%	258

Other funds holding CLGN

SDJVC

St. Denis J. Villere & Co New Orleans, Louisiana $838M AUM 14.24% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

LWMI

Legacy Wealth Management (Idaho) Boise, Idaho $243M AUM 8.27% 1-Year Est. Return

WPC

Waters Parkerson & Co New Orleans, Louisiana $2.03B AUM 17.65% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Pinnacle Associates's CLGN Position: Q2 2026 in Review

Pinnacle Associates increased its CollPlant Biotechnologies (CLGN) stake by 33% in Q2 2026, buying an estimated $69.9K and bringing the position to 73,166 shares worth $255K. The position accounts for ﹤0.01% of the portfolio, ranked #858.

Pinnacle Associates first reported a position in CLGN in Q2 2023 and has held it in 13 quarters since. The position peaked at $3.95M in Q2 2023. 15 funds tracked by Wall St. Rank hold CLGN as of Q2 2026.

Pinnacle Associates held 73,166 shares of CollPlant Biotechnologies worth $255K as of Q2 2026.
Pinnacle Associates bought 18,143 CollPlant Biotechnologies shares in Q2 2026, an estimated $69.9K.
CollPlant Biotechnologies made up ﹤0.01% of Pinnacle Associates's portfolio in Q2 2026, its #858 holding.
Pinnacle Associates first reported a position in CollPlant Biotechnologies in Q2 2023 and has held it in 13 quarters since.
Pinnacle Associates's CollPlant Biotechnologies position peaked at $3.95M in Q2 2023.
15 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q2 2026.

Based on Pinnacle Associates's 13F filing for Q2 2026, filed 3 Aug 2026.